The Financial Impact of Biosimilars
Introduction There is a coming wave of changes arriving soon to the pharmacy market in the form of [...]
Introduction There is a coming wave of changes arriving soon to the pharmacy market in the form of [...]
Introduction About 30 years ago I met with my then-business partner to think into the future and [...]
Introduction Today is the day! The Big Event of 2023 is the launch of multiple Humira biosimilars [...]
Introduction Aligning capitation rates with the line of business and risk selection of attributed members is an [...]
Although there are many variables influencing healthcare costs, the most important are unit cost and utilization. Unit cost [...]
Introduction I read the 725-page draft of the Deficit Reduction Act[1] so you don’t have to. Well, [...]
“Mother-May-I” is a classic kids’ game that teaches little ones to honor their mother by having players [...]
The story of consumer value in the Affordable Care Act (ACA) individual marketplaces echoes one of the [...]
Health care costs continue to increase faster than the rest of the economy. Recent projections by the [...]
Over the years much has been said about the issue of increasing costs of healthcare, its causes, [...]